HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomoyuki Yokoyama Selected Research

Hypoglycemia (Reactive Hypoglycemia)

1/2018CD36 is indispensable for nutrient homeostasis and endurance exercise capacity during prolonged fasting.
1/2014Fatty acid binding protein 4 and 5 play a crucial role in thermogenesis under the conditions of fasting and cold stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomoyuki Yokoyama Research Topics

Disease

5Heart Failure
01/2012 - 02/2002
3Myocardial Infarction
01/2019 - 11/2017
3Cardiovascular Diseases (Cardiovascular Disease)
09/2018 - 01/2007
3Obesity
09/2018 - 01/2007
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2013 - 08/2009
3Cardiomegaly (Heart Hypertrophy)
12/2012 - 10/2003
2Myocarditis (Carditis)
05/2022 - 02/2002
2Atherosclerosis
05/2021 - 01/2014
2Hypoglycemia (Reactive Hypoglycemia)
01/2018 - 01/2014
2Hypothermia
02/2015 - 01/2014
2Insulin Resistance
01/2014 - 08/2009
2Fibrosis (Cirrhosis)
01/2012 - 04/2008
2Obstructive Sleep Apnea
08/2009 - 01/2008
1COVID-19
05/2022
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2019
1Stable Angina
01/2019
1Ventricular Tachycardia
11/2017
1Neointima
11/2016
1Overnutrition
01/2014
1Idiopathic Pulmonary Fibrosis
01/2013
1Vascular Calcification
01/2013
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2013
1Hypertension (High Blood Pressure)
12/2012
1Hypertrophy
12/2012
1Cicatrix (Scar)
01/2012
1Apnea
01/2008
1Ischemia
01/2007
1Inflammation (Inflammations)
01/2007
1Sarcoidosis (Schaumann Disease)
12/2004
1Communicable Diseases (Infectious Diseases)
10/2003
1Hypoxia (Hypoxemia)
07/2002
1Heart Neoplasms
02/2002
1Body Weight (Weight, Body)
02/2002
1Necrosis
02/2002

Drug/Important Bio-Agent (IBA)

5Fatty Acids (Saturated Fatty Acids)IBA
01/2019 - 01/2012
4Fatty Acid-Binding ProteinsIBA
05/2021 - 11/2017
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2007 - 02/2002
3Proteins (Proteins, Gene)FDA Link
01/2019 - 07/2002
3Glucose (Dextrose)FDA LinkGeneric
01/2018 - 08/2009
3LeptinIBA
12/2012 - 01/2007
2Adrenergic Agents (Adrenergic Drugs)IBA
01/2019 - 09/2018
2AdipokinesIBA
09/2018 - 01/2008
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2014 - 12/2004
2Leptin ReceptorsIBA
12/2012 - 01/2007
2Connective Tissue Growth FactorIBA
01/2012 - 04/2008
2CytokinesIBA
01/2012 - 02/2002
2Messenger RNA (mRNA)IBA
01/2007 - 07/2002
1VaccinesIBA
05/2022
1TroponinIBA
05/2022
1mRNA VaccinesIBA
05/2022
1COVID-19 VaccinesIBA
05/2022
1Apolipoproteins E (ApoE)IBA
05/2021
1IncretinsIBA
01/2021
1AMP-Activated Protein KinasesIBA
01/2019
1fibroblast growth factor 21IBA
01/2019
1Becaplermin (PDGF-BB)FDA Link
11/2016
1Small Interfering RNA (siRNA)IBA
11/2016
1GlycogenIBA
02/2015
1Triglycerides (Triacylglycerol)IBA
02/2015
1Blood Glucose (Blood Sugar)IBA
02/2015
1Carrier Proteins (Binding Protein)IBA
01/2014
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2013
1LipidsIBA
01/2013
1Nonesterified Fatty Acids (NEFA)IBA
01/2013
1CalciumIBA
01/2013
1Eicosapentaenoic AcidIBA
01/2013
1Insulin (Novolin)FDA Link
08/2009
1N(epsilon)-hexanoyllysineIBA
08/2009
1p38 Mitogen-Activated Protein KinasesIBA
05/2008
1Prostaglandins FIBA
05/2008
1Biomarkers (Surrogate Marker)IBA
04/2008
1Hemoglobins (Hemoglobin)IBA
01/2008
1AdiponectinIBA
01/2008
1Biological ProductsIBA
01/2007
1AntibodiesIBA
01/2007
1Hormones (Hormone)IBA
01/2007
1Adrenergic Receptors (Adrenergic Receptor)IBA
03/2005
1AntioxidantsIBA
03/2005
1Carvedilol (Coreg)FDA LinkGeneric
03/2005
1ElementsIBA
07/2002
1Interleukin-1beta (Interleukin 1 beta)IBA
07/2002
1endothelial PAS domain-containing protein 1IBA
07/2002
1Atrial Natriuretic Factor (ANF)IBA
02/2002
1Interleukin-18 (Interleukin 18)IBA
02/2002
1Therapeutic UsesIBA
02/2002

Therapy/Procedure

1Therapeutics
01/2021
1Ligation
01/2007